INOVIO PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.42 USD | +0.53% |
|
+2.42% | +86.60% |
| 01:59pm | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
| May. 13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | +0.53% | +2.42% | +86.60% | +23.96% | -73.12% | 294M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- INO Stock
- Charts Inovio Pharmaceuticals, Inc.
- Comparison Chart
